Author Question: A client has been prescribed pyridostigmine for myasthenia gravis. The nurse would be alert for the ... (Read 73 times)

Yi-Chen · **on:** Jul 23, 2018

A client has been prescribed pyridostigmine for myasthenia gravis. The nurse would be alert for the development of which of the following?

A) Seizure disorder
B) Reduction of visual acuity
C) Abdominal discomfort
D) Cardiac arrhythmias

Question 2

When conducting client teaching with a client and his family about the prescribed cholinergic therapy for myasthenia gravis, which of the following would be most important to include? Select all that apply.

A) How to adjust dosage
B) Indications of drug underdosage
C) The need to monitor blood glucose levels
D) How to keep a record of response to therapy
E) The need to wear medical identification

joechoochoy · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

Ans: D
Feedback:
The nurse should monitor for cardiac arrhythmias as a general adverse reaction in the client. Seizure disorder, reduction of visual acuity, and abdominal discomfort are not pyridostigmine-related adverse reactions. Reduction of visual acuity is related to topical ophthalmics. When the client is receiving bethanechol chloride for urinary retention, the nurse needs to examine for abdominal discomfort, which is an adverse reaction of bethanechol chloride and not pyridostigmine.

Answer to Question 2

Ans: A, B, D, E
Feedback:
Client and family teaching should include signs and symptoms associated with under- and overdosage, instructions on how to adjust the dosage up or down, how to keep a record of the response to therapy, and the importance of wearing medical identification. There is no need for the client and family to monitor blood glucose levels.